SL
MRNA icon

Salomon & Ludwin’s Moderna MRNA Stock Holding History

Salomon & Ludwin’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03K Hold
28
– – ﹤0.01% 1964
2026
Q1 		$1.38K Hold
28
– – ﹤0.01% 1980
2025
Q4 		$901 Hold
28
– – ﹤0.01% 2068
2025
Q3 		$798 Hold
28
– – ﹤0.01% 2063
2025
Q2 		$848 Hold
28
– – ﹤0.01% 761
2025
Q1 		$794 Hold
28
– – ﹤0.01% 657
2024
Q4 		$1.16K Hold
28
– – ﹤0.01% 648
2024
Q3 		$1.87K Hold
28
– – ﹤0.01% 620
2024
Q2 		$3.33K Hold
28
– – ﹤0.01% 562
2024
Q1 		$2.98K Sell
28
-190
-87% -$19.2K ﹤0.01% 694
2023
Q4 		$22.5K Hold
218
– – ﹤0.01% 399
2023
Q3 		$22.5K Buy
+218
New +$24.3K ﹤0.01% 399

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Salomon & Ludwin's MRNA Position: Q2 2026 in Review

Salomon & Ludwin held its Moderna (MRNA) position steady in Q2 2026 at 28 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Salomon & Ludwin first reported a position in MRNA in Q3 2023 and has held it in 12 quarters since. The position peaked at $22.5K in Q4 2023. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Salomon & Ludwin held 28 shares of Moderna worth $2.03K as of Q2 2026.
  • Salomon & Ludwin left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1964 holding.
  • Salomon & Ludwin first reported a position in Moderna in Q3 2023 and has held it in 12 quarters since.
  • Salomon & Ludwin's Moderna position peaked at $22.5K in Q4 2023.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.